A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

NCT00004585 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate, Lamivudine and Zidovudine
DRUG: Lamivudine/Zidovudine
DRUG: Abacavir sulfate
DRUG: Efavirenz

Sponsor

Glaxo Wellcome